FDA panel backs Pfizer's drug for kidney cancer
Pfizer Inc won unanimous expert backing for its Inlyta experimental drug for patients with advanced kidney cancer.
View full post on Yahoo! Health News
backs, Cancer, drug, kidney, Panel, Pfizer'sPfizer Inc won unanimous expert backing for its Inlyta experimental drug for patients with advanced kidney cancer.
View full post on Yahoo! Health News
Tags: backs, Cancer, drug, kidney, Panel, Pfizer'sPowered by Yahoo! Answers